medline.ch Onkologie Urologische Tumoren

	Clinical Oncological Tolerance of Testosterone Replacement Therapy Over Two Years Among Patients With High-Risk or Very High-Risk Prostate Cancer Undergoing Radiotherapy. Cureus Shigehara K, Naito R, Kawahara T, Kato Y, Shinzawa R, Yaegshi H, Nohara T, Izumi K, Mizokami A. PMID: 41127766 [PubMed - in process]
	Mucinous adenocarcinoma of the prostate: a rare tumor - case report and literature review. J Ultrason Montatore M, Eusebi L, Masino F, Balbino M, Guglielmi G. PMID: 41127570 [PubMed - in process]
	BlaCancer: a mobile health solution for enhancing bladder cancer care. BMC Urol Assi A, Jalbout J, Youssef B, Diab E, Kourie HR. PMID: 41126158 [PubMed - indexed for MEDLINE]
	Diagnostic value of serum DR-70 levels, a new fibrin-related biomarker, in bladder cancer patients. BMC Urol Karakanl, Kutlutürk EG, Polat EC, Ötünçtemur A, Merder E, Dursun M, Özcan L. PMID: 41126111 [PubMed - indexed for MEDLINE]
	[Update on the pathologic features of penile cancer]. Urologie Regauer S. PMID: 41125967 [PubMed - as supplied by publisher]
	Maximal anatomic bladder neck preservation at the prostatic origin (MANO) in robotic radical prostatectomy: does prostate size matter? J Robot Surg Sakthivel DK, Prabhakar P, Iyub MJR, Ozambela M Jr, Manoharan M. PMID: 41125940 [PubMed - indexed for MEDLINE]
	Should MRI-invisible low-risk prostate cancer be managed differently? A retrospective study of upgrading risk and future intervention. Urol Oncol Jang JW, Handa N, Alam R, Schnauss M, Neill C, Kumar S, Huang M, Murphy AB, Ross AE, Patel HD. PMID: 41125499 [PubMed - as supplied by publisher]
	Clinical Efficacy and Challenges of Cancer-Testis Antigen Vaccines in Advanced Solid Tumors: A Systematic Review and Meta-Analysis. Crit Rev Oncol Hematol Jiang J, Li L, Yu Z, Wang K, Ma J, Li D, Guo Z, Wang L, Zhang H, Xu L, Zhang M. PMID: 41125171 [PubMed - as supplied by publisher]
	ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer. N Engl J Med Powles T, Kann AG, Castellano D, Gross-Goupil M, Nishiyama H, Bracarda S, Bjerggaard Jensen J, Makaroff L, Jiang S, Ku JH, Park SH, Reig Torras O, Ye D, Maruzzo M, Necchi A, Morales-Barrera R, Giunta EF, Lee JL, Tortora G, Ürün Y, Dolowy L, Erdem D, Pinto A, Grando F, Zou W, Assaf ZJ, Vuky J, Degaonkar V, Steinberg EE, Bellmunt J, Gschwend JE, IMvigor011 Investigators. PMID: 41124204 [PubMed - as supplied by publisher]
	The combination of prostate health index and multiparametric magnetic resonance imaging in prostate cancer diagnosis: efficacy analysis in different PSA ranges and its clinical decision-guiding value. World J Urol Pan JF, Chen YZ, Wang SY, Zhao ZY, Ren DW, Su R, Jia XL, Jiang JH, Ma Q. PMID: 41123711 [PubMed - indexed for MEDLINE]
	Evaluating the learning curve for single-port radical prostatectomy: a multi-institutional cohort analysis. World J Urol Finocchiaro A, Buffi N, Aljoulani M, Almajedi M, Stephens A, Viganò S, Bertini A, Biasatti A, Valenzi FM, Ficarra V, Sorce G, Salonia A, Briganti A, Montorsi F, Lughezzani G, Vourganti S, Autorino R, Crivellaro S, Nelson RJ, Rogers C, Abdollah F. PMID: 41123690 [PubMed - indexed for MEDLINE]
	Survival outcomes and prognostic factors in muscle-invasive bladder cancer: a retrospective cohort study from a Saudi Arabian tertiary center. Arch Ital Urol Androl Badheeb AM, Alkhanbash O, Alzubaidi Q, Al Asmari A, Eltohamie DA, Ahmed F, Ben Yahya EA, Alkarak S, Baslasel OS, Aman A, Seada I, Abubakar A, Badheeb M. PMID: 41123570 [PubMed - as supplied by publisher]
	Development and evaluation of a lymph node invasion risk prediction model in intermediate- and high-risk prostate cancer patients. Acta Oncol Ramberg H, Zucknick M, Barletta F, Davik P, Nybøen Å, Eri LM, Sivanesan S, Hole KH, Hompland T, Prestbakk SO, Gandaglia G, Bathen TF, Briganti A, Berge V, Austild Tasken K. PMID: 41123130 [PubMed - indexed for MEDLINE]
	Occupational hazards and bladder cancer-An umbrella review of the risk in workers exposed over the past 30 years. Front Public Health Mandanach C, Handra CM, Rascu A, Hohor S, Gurzu IL, Otelea MR, Rascu ASC. PMID: 41122539 [PubMed - indexed for MEDLINE]
	Treatment of aggressive prostate cancer with triptorelin in real life in France: the TALISMAN study. Ther Adv Urol Lebret T, Crehange G, Pello-Leprince-Ringuet N, Perrot V, Rigaud J. PMID: 41122488 [PubMed]
	Orthopedic interventions and outcomes in patients with metastatic renal cell carcinoma: a systematic review. Ther Adv Med Oncol Al Bochi A, Madani MT, El-Kassem M, Fadel M, Rajeh A, Boldt G, Fernandes R. PMID: 41122311 [PubMed]
	Clinicopathological and Molecular Comparative Analysis of Hereditary vs. Sporadic Fumarate Hydratase-deficient Leiomyomatosis and Renal Carcinoma. Curr Pharm Biotechnol Chen Q, Naibijiang P, Hu Y, Du Q, Kuyaxikezi N. PMID: 41121474 [PubMed - as supplied by publisher]
	MED15-TFE3 rearranged renal cell carcinoma: a subtype of TFE3-rearranged renal cell carcinoma with unique clinicopathologic features and better prognosis. World J Surg Oncol Deng Z, Xu Y, Duan E, Zhang X, Dong X, Guo H, Gan W. PMID: 41121311 [PubMed - indexed for MEDLINE]
	Renal cell carcinoma organoids for precision medicine: bridging the gap between models and patients. J Transl Med Gao J, Luo H, Wang S, Zhou C, Li Z, Kimhoy C, Liang G, Chen S. PMID: 41121193 [PubMed - indexed for MEDLINE]
	Serum lactate Dehydrogenase-to-Albumin ratio in upper tract urothelial carcinoma: A promising prognostic biomarker. BMC Urol Wang Q, Zheng L, Ye J, Liao X, Chen Z, Wang X, Zhang C, Wei Q, Bao Y. PMID: 41121139 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 171076

Seite 1 von 8554

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung